Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 222 pembrolizumab 199 Carboplatin 173 Cisplatin 168 Gemcitabine 167 Paclitaxel 153 Docetaxel 139 Rituximab 137 Bevacizumab 137 Radiotherapy 136 Dexamethasone 126 Nivolumab 125 Capecitabine 103 fludarabine 102 Pemetrexed 92 fludarabine phosphate 91 Fluorouracil 91 Doxorubicin 85 Oxaliplatin 79 Etoposide 77 Cytarabine 77 Bortezomib 76 Erlotinib Hydrochloride 74 Leucovorin 72 Filgrastim 68 Lenalidomide 67 Calcium Dobesilate 66 Irinotecan 65 atezolizumab 62 Radiation 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Has results × Tissue Array Analysis × Clear all

NCT02236546 2017-04-13

FDG-PET in Advanced Melanoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated

3 enrolled 4 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡